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Abstract
The Israel Journal of Health Policy Research (IJHPR) will soon be completing its fifth year of publication. In the 5
years since the IJHPR’s launch in January 2012, it has published over 250 articles, achieved an impact factor of 1.35,
and secured a place in many of the leading journal databases including, most recently, Medline. The IJHPR’s annual
rate of submissions continues to increase, with more and more submissions focusing on major system-wide
developments in Israeli health care.
The journal’s accomplishments reflect the hard work and significant contributions of its authors, reviewers,
commentators, editorial board members and sponsor - the National Institute for Health Policy Research.
New initiatives for 2017 include symposia highlighting the implications for Israeli health policy of selected IJHPR
articles and a collection of essays by editors of leading health policy journals about the opportunities and
challenges currently facing journals in our field.
In parallel with the growth and maturation of the IJHPR, there have also been important advances in the volume,
quality and visibility of Israeli health services and health policy research more generally. The number of Israeli health
care professionals engaged in writing and reviewing manuscripts has increased significantly, and there is growing
interest among international journals in manuscripts about Israeli health care. We are confident that in the years
ahead we will continue to witness significant achievements for both the journal and for the Israeli health policy and
health services research community.
The Israel Journal of Health Policy Research (IJHPR) will
soon be completing its fifth year of publication. In the
5 years since the IJHPR’s launch in January 2012, it has
published over 250 articles, achieved an impact factor of
1.35, and secured a permanent place in many of the
leading journal databases including the Social Science
Citation Index, the Web of Science, Scopus, PubMed
and – 2 months ago - Medline.
Medline is recognized as the most important and most
comprehensive bibliographic resource in the field of bio-
medicine, and it is managed by the largest medical li-
brary in the world - the National Library of Medicine
(NLM) [1, 2]. It is also one the world’s most selective da-
tabases of peer-reviewed journals.
The IJHPR has been included in a related NLM data-
base – PubMed – since mid-2012. The recent accept-
ance into Medline is an indication of the journal’s
progress in terms of quality, impact and reputation. Ac-
ceptance into Medline should also help to increase the
journal’s citation rate (though not immediately), as Med-
line is one of the main search engines used in systematic
reviews. The indexing of IJHPR in Medline will begin
with volume 5 (2016).
Another important recent achievement is that we
are receiving more manuscripts about major system-
wide developments in the Israeli health care arena.
The topics covered include: the national initiative to
increase health care equity [3], the pediatric dental
reform [4], medical education [5, 6], advanced prac-
tice providers [7], tobacco control [8], and growing
pharmaceutical expenses [9, 10]. In addition, since
our last editorial [11] (December 2014), the IJHPR
has published its first article by a Nobel Prize laureate
[12], and its first contributions from China [13] and
India [14].
The IJHPR’s rate of submissions has risen substantially
since the journal’s launch in 2012, with over 100 manu-
scripts submitted over the course of 2016. In conjunction
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with the increase in submissions, we have been steadily
raising the journal’s quality bar.
The journal’s accomplishments are due, first and fore-
most, to the many authors who choose to submit their
manuscripts to the IJHPR and, secondly, to the highly
professional reviewers whose detailed comments have
often made a major contribution to the quality of the
published articles. Almost all of Israel’s universities and
research centers are represented among the IJHPR’s au-
thors, and many professionals based at Israel’s Ministry
of Health, health plans, and hospitals have also pub-
lished in the IJHPR. The authors’ fields of expertise, and
their IJHPR articles, span a very broad range of aspects
of health policy – just as we had hoped when we
launched the journal 5 years ago [15]. The journal also
continues to draw in commentaries from internationally
renowned scholars from all around the world. Their
commentaries underscore the international and univer-
sal significance of the Israeli studies and bring the ex-
perience of other countries to bear on the challenges
facing Israeli health care.
In addition, the IJHPR considers and publishes re-
search papers initiated by authors outside Israel, so long
as they address a subject or contain information relevant
to health services and health policy in Israel. The num-
ber of such submissions and publications is also increas-
ing, contributing to the IJHPR’s being both an Israeli
and an international journal.
The journal could not exist without the ongoing
support of its sponsor, the National Institute for Health
Policy Research. In addition to material support, the
National Institute and its leadership provides the journal
with important substantive input, advice and guidance.
We are also profoundly thankful to the members of the
editorial board for their input on journal policy and em-
phases as well as sharing in the nitty gritty work of review-
ing manuscripts and identifying additional reviewers.
We are planning to launch two new initiatives over
the coming year. First, in honor of the IJHPR’s fifth anni-
versary we have invited the editors of several leading
health policy and health services journals to write essays
about the opportunities and challenges currently facing
journals in our field. We hope to publish these essays as
a special collection.
Second, in conjunction with the leadership of the
National Institute for Health Policy Research, we will be
experimenting with high-level symposia which will ex-
plore the policy implications of one or more IJHPR arti-
cles on a pressing policy issue. The first such symposium
will be on the growing expenditures on cancer medica-
tions and the program will include presentations by au-
thors of the relevant IJHPR articles [9, 10, 16, 17], along
with presentations from Israeli health care leaders who are
grappling with this issue.
In conclusion, we are pleased to share with you several
important developments regarding the publication of ar-
ticles about Israeli health care (that go well beyond those
articles published in the IJHPR).
 The number of health policy articles (based on a
keyword search of the Web of Science) with at least
one Israeli-based author increased by over 80%
between 2007–2011 and 2012–2016.
 Editors of several leading international health and
health policy journals have expressed interest in
publishing more articles about Israel in the years
ahead, and various concrete outreach efforts are
already underway.
 A recent study commissioned by Israel’s National
Institute for Health Policy Research found that
approximately 40% of the studies that they had
funded have generated at least one article in a peer-
reviewed journal. This figure is higher than many of
us expected, and chances are that – now that this
measure is being monitored and publicized - it will
increase in the years ahead.
In short, the number of articles about Israeli health care
is growing and can be expected to grow further in the fu-
ture. We at the IJHPR are proud to be playing our small
part in this. The growth is beneficial not only for Israeli re-
searchers and all the journals involved; it is also extremely
important for progress in health care in Israel and beyond.
We are confident that the years ahead will also be years of
significant achievements for both the journal and for the
Israeli health policy/health services research community.
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